Reference:
Kory, P., Meduri, G. U., Iglesias, J., Varon, J., & Marik, P. E. (2021). Review of the emerging evidence supporting the efficacy of ivermectin in the prophylaxis and treatment of COVID-19. Front-Line COVID-19 Critical Care Alliance.
Summary:
This article by the Front Line COVID-19 Critical Care Alliance reviews the growing evidence supporting ivermectin’s effectiveness in both
preventing and treating COVID-19. Initially created in March 2020, the Alliance aimed to develop treatment protocols based on emerging
scientific data. The authors highlight multiple studies showing ivermectin’s antiviral and anti-inflammatory properties, demonstrating
significant improvements in clinical outcomes across various trials. They refer to “natural experiments” from regions where ivermectin was
widely distributed, which correlated with decreases in COVID-19 cases and fatalities. The authors argue for the global adoption of ivermectin, citing its safety, low cost, and historical use as a treatment. They recommend integrating ivermectin into national treatment guidelines, alongside other supportive therapies, to combat the ongoing pandemic.